(Q45147412)

English

The prevalence of tardive dyskinesia after a nine month naturalistic randomized trial comparing olanzapine with conventional treatment for schizophrenia and related disorders

scientific article published on 12 November 2004

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

The prevalence of tardive dyskinesia after a nine month naturalistic randomized trial comparing olanzapine with conventional treatment for schizophrenia and related disorders (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

Jair de Jesus Mari

1

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Mauricio S Lima

2

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Anna Niccolai Costa

3

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Neusa Alexandrino

4

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Salomao Rodrigues-Filho

5

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Irismar Reis de Oliveira

6

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Gary D Tollefson

7

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

publication date

12 November 2004

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

European Archives of Psychiatry and Clinical Neuroscience

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

254

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

356-361

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications. Results of the Yale Tardive Dyskinesia Study.

1 reference

https://api.crossref.org/works/10.1007%2FS00406-004-0514-1

21 January 2018

Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial

1 reference

https://api.crossref.org/works/10.1007%2FS00406-004-0514-1

21 January 2018

Dopamine D(2) receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient

1 reference

https://pubmed.ncbi.nlm.nih.gov/15538607

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised double-blind comparison of the incidence of tardive dyskinesia in patients with schizophrenia during long-term treatment with olanzapine or haloperidol

1 reference

https://pubmed.ncbi.nlm.nih.gov/15538607

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15538607

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Atypical antipsychotics: mechanism of action.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15538607

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Olanzapine for schizophrenia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15538607

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol

1 reference

https://pubmed.ncbi.nlm.nih.gov/15538607

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pragmatic randomised controlled trials in psychiatry

1 reference

https://pubmed.ncbi.nlm.nih.gov/15538607

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Olanzapine versus haloperidol: acute phase results of the international double-blind olanzapine trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15538607

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Canadian trends in mortality from mental disorders, 1965-1983.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15538607

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radioreceptor binding profile of the atypical antipsychotic olanzapine

1 reference

https://pubmed.ncbi.nlm.nih.gov/15538607

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Research Diagnoses for Tardive Dyskinesia

1 reference

https://pubmed.ncbi.nlm.nih.gov/15538607

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Review of incidence studies of tardive dyskinesia associated with typical antipsychotics

1 reference

https://pubmed.ncbi.nlm.nih.gov/15538607

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tardive dyskinesias and antipsychotics: a review

1 reference

https://pubmed.ncbi.nlm.nih.gov/15538607

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predicting the long-term risk of tardive dyskinesia in outpatients maintained on neuroleptic medications.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15538607

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute administration of haloperidol induces apoptosis of neurones in the striatum and substantia nigra in the rat.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15538607

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/15538607

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00406-004-0514-1

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45147412&oldid=2207118725"